Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome

References

• Nault JC, Sutter O, Nahon P, et al. Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations. J Hepatol. 2018;68(4):783–797.
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693.
   PubMed Web of Science ®Google Scholar
• European association for the study of the liver. Electronic address eee, european association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
   PubMed Web of Science ®Google Scholar
• Vouche M, Habib A, Ward TJ, et al. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology. 2014;60(1):192–201.
   PubMed Web of Science ®Google Scholar
• Kwak MH, Lee MW, Ko SE, et al. Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma. Ultrasonography. 2022;41(3):543–552.
   PubMed Web of Science ®Google Scholar
• Mukund A, Ramalingam R, Anandpara KM, et al. Efficacy and safety of percutaneous microwave ablation for hepatocellular carcinomas <4 cm in difficult location. BJR. 2020;93(1116):20191025.
   Google Scholar
• Xu X-L, Liu X-D, Liang M, et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Radiology. 2018;287(2):461–472.
   PubMed Web of Science ®Google Scholar
• Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34(6):863–869.
   PubMed Web of Science ®Google Scholar
• Ozen M, Birmingham E, Raissi D. Re: liver tumor ablation in difficult locations: microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma. Clin Imaging. 2022;85:7.
   PubMed Web of Science ®Google Scholar
• Makovich Z, Logemann J, Chen L, et al. Liver tumor ablation in difficult locations: microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma. Clin Imaging. 2021;71:170–177.
   PubMed Web of Science ®Google Scholar
• Smolock AR, Lubner MG, Ziemlewicz TJ, et al. Microwave ablation of hepatic tumors abutting the diaphragm is safe and effective. AJR Am J Roentgenol. 2015;204(1):197–203.
   PubMed Web of Science ®Google Scholar
• Shin SW, Cho SK, Hyun D, et al. Guidewire-catheter induced hydrodissection to assist radiofrequency ablation for subcapsular hepatocellular carcinoma with iodized oil retention in patients with failed artificial ascites due to perihepatic adhesion. Diagn Interv Radiol. 2021;27(6):746–753.
   PubMed Web of Science ®Google Scholar
• Cha DI, Kang TW, Song KD, et al. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. Eur Radiol. 2019;29(5):2706–2715.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM. Recent advances in the image-guided tumor ablation of liver malignancies: radiofrequency ablation with multiple electrodes, Real-Time multimodality fusion imaging, and new energy sources. Korean J Radiol. 2018;19(4):545–559.
   PubMed Web of Science ®Google Scholar
• Bai XM, Cui M, Yang W, et al. The 10-year survival analysis of radiofrequency ablation for solitary hepatocellular carcinoma 5 cm or smaller: primary versus recurrent HCC. Radiology. 2021;300(2):458–469.
   PubMed Web of Science ®Google Scholar
• Song I, Rhim H, Lim HK, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol. 2009;19(11):2630–2640.
   PubMed Web of Science ®Google Scholar
• Korean Liver Cancer A, National Cancer Center GK Korean liver cancer association-national cancer center Korea practice guidelines for the management of hepatocellular carcinoma. Korean J Radiol 2019. 2018;20:1042–1113.
   Web of Science ®Google Scholar
• Head HW, Dodd GD, 3rd, Dalrymple NC, et al. Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology. 2007;243(3):877–884.
   PubMed Web of Science ®Google Scholar
• Kang TW, Rhim H, Lee MW, et al. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy. AJR Am J Roentgenol. 2011;196(4):907–913.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang H, Yang W, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5):1579–1590.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee MW, Kim PN, et al. Outcome of no-touch radiofrequency ablation for small hepatocellular carcinoma: a multicenter clinical trial. Radiology. 2021;301(1):229–236.
   PubMed Web of Science ®Google Scholar
• Pillai K, Akhter J, Chua TC, et al. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine . 2015;94(9):e580.
   PubMed Web of Science ®Google Scholar
• Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-Event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533–540.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Filippiadis DK, Binkert C, Pellerin O, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–1146.
   PubMed Web of Science ®Google Scholar
• Yang W, Yan K, Wu GX, et al. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: strategies and long-term outcomes. World J Gastroenterol. 2015;21(5):1554–1566.
   PubMed Web of Science ®Google Scholar
• Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3(5):317–325.
   PubMed Web of Science ®Google Scholar
• Chang W, Lee JM, Lee DH, et al. Comparison of switching bipolar ablation with multiple cooled wet electrodes and switching monopolar ablation with separable clustered electrode in treatment of small hepatocellular carcinoma: a randomized controlled trial. PLOS One. 2018;13(2):e0192173.
   PubMed Web of Science ®Google Scholar
• Choi JW, Lee JM, Lee DH, et al. Radiofrequency ablation using a separable clustered electrode for the treatment of hepatocellular carcinomas: a randomized controlled trial of a dual-switching monopolar mode versus a single-switching monopolar mode. Korean J Radiol. 2021;22(2):179–188.
   PubMed Web of Science ®Google Scholar
• Choi JW, Lee JM, Lee DH, et al. Switching monopolar radiofrequency ablation using a separable cluster electrode in patients with hepatocellular carcinoma: a prospective study. PLoS One. 2016;11(8):e0161980.
   PubMed Web of Science ®Google Scholar
• Song SG, Hur YH, Cho JY, et al. Pleural effusion after hepatic radiofrequency ablation with artificial ascites: clinical spectrum and significance. J Vasc Interv Radiol. 2020;31(10):1636–1644 e1631.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Lee JM, Lee DH, et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66(2):347–354.
   PubMed Web of Science ®Google Scholar
• Tinguely P, Paolucci I, Ruiter SJS, et al. Stereotactic and robotic minimally invasive thermal ablation of malignant liver tumors: a systematic review and meta-analysis. Front Oncol. 2021;11:713685.
   PubMed Web of Science ®Google Scholar
• Schaible J, Pregler B, Verloh N, et al. Improvement of the primary efficacy of microwave ablation of malignant liver tumors by using a robotic navigation system. Radiol Oncol. 2020;54(3):295–300.
   PubMed Web of Science ®Google Scholar